Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093973705> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W2093973705 endingPage "6" @default.
- W2093973705 startingPage "6" @default.
- W2093973705 abstract "Objectives: The prognostic significance and the frequency of occurrence of serum alkaline-phosphatase fare in patients with advanced prostate cancer commenced on hormonal treatment is controversial. Present study was carried out to clarify its prognostic value and the frequency of occurrence in relation to progression and survival in these patients. Methods: Case notes of 168 (101 metastatic and 67 locally advanced) patients with advanced carcinoma of the prostate diagnosed between July 1984 through December 1995 were analysed retrospectively. All cases were followed until death or until March 1997 when the cases were censored. Serum alkaline-phosphatase values obtained immediately prior to and within 6 weeks of initiating the hormonal therapy were analysed in relation to progression free and overall survival. Results: Of the total of 168 evaluable cases, 101(60.1 %) had metastatic and 67 (39.9%) locally advanced tumours. Mean pre-treatment serum alkaline-phosphatase levels were higher (350IU/1) in the group which exhibited fare phenomenon post-treatment than the other which didn't (180 IU/1). Overall, flare activity in SAP levels was observed in 59 (35.1 %) of the total cases. Also, a greater proportion of the cases with metastatic disease had SAP flare than the other who had locally advanced disease (52.4% verses 8.9%). Flare in SAP levels were associated with decreased progression free and overall survival (p=0.001; p=0.002); greater the rise in SAP levels posttreatment, worse the prognosis. Conclusions: A significant proportion of patients with advanced carcinoma of the prostate have flare in SAP levels soon after initiating the treatment. We confirm that the flare activity in SAP levels is a negative prognostic indicator and it is possible to identify early treatment failures by frequent measurements of SAP levels during first 6 weeks of commencing the therapy. The significance of SAP fare and androgen resistance is discussed." @default.
- W2093973705 created "2016-06-24" @default.
- W2093973705 creator A5075004641 @default.
- W2093973705 date "2000-01-01" @default.
- W2093973705 modified "2023-10-18" @default.
- W2093973705 title "The significance of early changes in serum alkaline-phosphatase levels following endocrine treatment in patients with advanced prostate cancer" @default.
- W2093973705 doi "https://doi.org/10.4103/0970-1591.41004" @default.
- W2093973705 hasPublicationYear "2000" @default.
- W2093973705 type Work @default.
- W2093973705 sameAs 2093973705 @default.
- W2093973705 citedByCount "1" @default.
- W2093973705 countsByYear W20939737052018 @default.
- W2093973705 crossrefType "journal-article" @default.
- W2093973705 hasAuthorship W2093973705A5075004641 @default.
- W2093973705 hasConcept C121608353 @default.
- W2093973705 hasConcept C126322002 @default.
- W2093973705 hasConcept C126894567 @default.
- W2093973705 hasConcept C134018914 @default.
- W2093973705 hasConcept C143998085 @default.
- W2093973705 hasConcept C160160445 @default.
- W2093973705 hasConcept C181199279 @default.
- W2093973705 hasConcept C185592680 @default.
- W2093973705 hasConcept C2780192828 @default.
- W2093973705 hasConcept C42407357 @default.
- W2093973705 hasConcept C46699223 @default.
- W2093973705 hasConcept C55493867 @default.
- W2093973705 hasConcept C71315377 @default.
- W2093973705 hasConcept C71924100 @default.
- W2093973705 hasConceptScore W2093973705C121608353 @default.
- W2093973705 hasConceptScore W2093973705C126322002 @default.
- W2093973705 hasConceptScore W2093973705C126894567 @default.
- W2093973705 hasConceptScore W2093973705C134018914 @default.
- W2093973705 hasConceptScore W2093973705C143998085 @default.
- W2093973705 hasConceptScore W2093973705C160160445 @default.
- W2093973705 hasConceptScore W2093973705C181199279 @default.
- W2093973705 hasConceptScore W2093973705C185592680 @default.
- W2093973705 hasConceptScore W2093973705C2780192828 @default.
- W2093973705 hasConceptScore W2093973705C42407357 @default.
- W2093973705 hasConceptScore W2093973705C46699223 @default.
- W2093973705 hasConceptScore W2093973705C55493867 @default.
- W2093973705 hasConceptScore W2093973705C71315377 @default.
- W2093973705 hasConceptScore W2093973705C71924100 @default.
- W2093973705 hasIssue "1" @default.
- W2093973705 hasLocation W20939737051 @default.
- W2093973705 hasLocation W20939737052 @default.
- W2093973705 hasOpenAccess W2093973705 @default.
- W2093973705 hasPrimaryLocation W20939737051 @default.
- W2093973705 hasRelatedWork W1508288034 @default.
- W2093973705 hasRelatedWork W1966504330 @default.
- W2093973705 hasRelatedWork W1966775726 @default.
- W2093973705 hasRelatedWork W1979139803 @default.
- W2093973705 hasRelatedWork W2030889776 @default.
- W2093973705 hasRelatedWork W2037631372 @default.
- W2093973705 hasRelatedWork W2040058909 @default.
- W2093973705 hasRelatedWork W2132898409 @default.
- W2093973705 hasRelatedWork W2748952813 @default.
- W2093973705 hasRelatedWork W4249176446 @default.
- W2093973705 hasVolume "17" @default.
- W2093973705 isParatext "false" @default.
- W2093973705 isRetracted "false" @default.
- W2093973705 magId "2093973705" @default.
- W2093973705 workType "article" @default.